Jay Skyler, MD, MACP
Dr. Skyler is currently Professor of Medicine, Pediatrics, and Psychology in the Division of Endocrinology, Diabetes, and Metabolism at the University of Miami, Deputy Director for Clinical Research and Academic Programs at the Diabetes Research Institute, University of Miami, and Adjunct Professor of Pediatrics at the Barbara Davis Center for Childhood Diabetes, University of Colorado. For 22 years, Dr. Skyler was Study Chairman for the National Institutes of Health (NIH)-sponsored Diabetes Prevention Trial for T1DM (DPT-1) and its successor the NIH T1DM TrialNet Clinical Trials Study Group (TrialNet), clinical trials networks aimed at preventing T1D or interdicting the T1D disease process. Dr. Skyler is closely involved with many scientific societies and has served as President of the American Diabetes Association, the International Diabetes Immunotherapy Group, and the Southern Society for Clinical Investigation; and Vice-President of the International Diabetes Federation. He was founding Editor-in-Chief of Diabetes Care and founding Scientific Editor of the International Diabetes Monitor, and currently is Senior Editor of Diabetes Technology & Therapeutics.
Dr. Skyler is a 1969 graduate of Jefferson Medical College. He did postgraduate training at Duke University and NIH.